Bladder cancer statistics

Cases

New cases of bladder cancer, 2014-2016 average, UK

Deaths

Deaths from bladder cancer, 2016, UK.

Survival

Survive bladder cancer for 10 or more years, 2010-11, England and Wales

Preventable cases

Bladder cancer cases are preventable, UK, 2015

 

  • There are around 10,200 new bladder cancer cases in the UK every year, that's 28 every day (2014-2016).
  • Bladder cancer is the 10th most common cancer in the UK, accounting for 3% of all new cancer cases (2016).
  • In females in the UK, bladder cancer is the 15th most common cancer, with around 2,800 new cases in 2016.
  • In males in the UK, bladder cancer is the 8th most common cancer, with around 7,200 new cases in 2016.
  • Incidence rates for bladder cancer in the UK are highest in people aged 85 to 89 (2014-2016).
  • Since the early 1990s, bladder cancer incidence rates have decreased by around two-fifths (41%) in the UK. Rates in females have decreased by almost two-fifths (39%), and rates in males have decreased by almost half (45%).
  • Over the last decade, bladder cancer incidence rates have decreased by almost a sixth (16%) in the UK. Rates in males have decreased by around a fifth (19%), and rates in females have decreased by almost a sixth (16%).
  • Around a quarter of bladder cancer cases are diagnosed at a late stage in England (2014) and Northern Ireland (2010-2014).
  • Incidence rates for bladder cancer are projected to fall by 34% in the UK between 2014 and 2035, to 13 cases per 100,000 people by 2035.
  • Bladder cancer in England is more common in people living in the most deprived areas.
  • Bladder cancer is more common in White people than in Asian or Black people.
  • An estimated 69,100 people who had previously been diagnosed with bladder cancer were alive in the UK at the end of 2010.

See more in-depth bladder cancer incidence statistics

  • There are around 5,300 bladder cancer deaths in the UK every year, that's 15 every day (2014-2016).
  • Bladder cancer is the 9th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2016).
  • In males in the UK, bladder cancer is the 7th most common cause of cancer death, with around 3,600 deaths in 2016.
  • In females in the UK, bladder cancer is the 13th most common cause of cancer death, with around 1,800 deaths in 2016.
  • Mortality rates for bladder cancer in the UK are highest in people aged 90+ (2014-2016).
  • Since the early 1970s, bladder cancer mortality rates have decreased by almost a quarter (23%) in the UK. Rates in males have decreased by a third (33%), and rates in females have decreased by a seventh (14%).
  • Over the last decade, bladder cancer mortality rates have decreased by around a twentieth (6%) in the UK. Rates in males have decreased by around a tenth (9%), and rates in females have decreased by almost a tenth (8%).
  • Mortality rates for bladder cancer are projected to fall by 14% in the UK between 2014 and 2035, to 9 deaths per 100,000 people by 2035.
  • Bladder cancer deaths in England are more common in people living in the most deprived areas.

See more in-depth bladder cancer mortality statistics

  • Half (50%) of people diagnosed with bladder cancer in England and Wales survive their disease for ten years or more (2010-11).
  • More than half (53%) of people diagnosed with bladder cancer in England and Wales survive their disease for five years or more (2010-11).
  • More than 7 in 10 (72%) people diagnosed with bladder cancer in England and Wales survive their disease for one year or more (2010-11).
  • Bladder cancer survival is higher in men than women.
  • Almost three-quarters of men in England with bladder cancer diagnosed aged 15-49 survive their disease for five years or more, compared with more than 4 in 10 men diagnosed aged 80 and over (2009-2013).
  • Almost 6 in 10 women in England diagnosed with bladder cancer aged 50-59 survive their disease for five years or more, compared to less than a third of women diagnosed aged 80 and over (2009-2013).
  • Bladder cancer survival trends are difficult to interpret because of changes in classification and coding practices.
  • In the 1970s, a third (33%) of people diagnosed with bladder cancer survived their disease beyond ten years, now it's half (50%).
  • When diagnosed at its earliest stage, more than 8 in 10 people with bladder cancer will survive their disease for five years or more, compared with around 1 in 10 people when the disease diagnosed at the latest stage.
  • Five-year relative survival for bladder cancer in men is above the European average in England, Wales and Northern Ireland but below the European average in Scotland
  • Five-year relative survival for bladder cancer in women is similar to the European average in England, Wales and Northern Ireland but below the European average in Scotland.

See more in-depth bladder cancer survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 50 UK males and 1 in 133 UK females will be diagnosed with bladder cancer in their lifetime.
  • 49% of bladder cancer cases in the UK are preventable.
  • 45% of bladder cancer cases in the UK are caused by smoking.
  • 6% of bladder cancer cases in the UK are caused by workplace exposures.
  • 2% of bladder cancer cases in the UK are caused by ionising radiation.

See more in-depth bladder cancer risk statistics

  • 'Two-week wait' is the most common route to diagnosing bladder cancer.
  • Two week wait is the route with the highest proportion of cases diagnosed at an early stage, for bladder cancer.
  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ and ‘62 day wait’ are not met by any country for urological cancers.
  • 49% of patients diagnosed with bladder cancer have surgery to remove the tumour as part of their primary cancer treatment.
  • 21% of patients diagnosed with bladder cancer have radiotherapy as part of their primary cancer treatment.
  • 34% of patients diagnosed with bladder cancer have chemotherapy as part of their primary cancer treatment.

Read more in-depth bladder cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

We’re now on twitter.

Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs